TABLE 3.

Mast cell tumors (MCT) results populations

	Coarse fractionated group	Fractionated group	P value (significance ≤.05)
Patient median age (y)	8 (range, 1‐13.7)	8 (range, 2‐13)
Total number MCT	211	91
Cutaneous	165 (78%)	79 (87%)	.57
SC	43 (20%)	12 (13.2%)	.49
Not recorded	3 (1.4%)	0	NA
Stage 1	150 (71%)	68 (75%)	.79
Stage 2	25 (12%)	17 (19%)	.17
Stage 3	4 (1.8%)	6 (6.6%)	.04
Stage not recorded	32 (15%)	0	NA
Received any chemotherapy	46 (22%)	25 (27%)	.4
Incomplete margins	186 (61.6%)	83 (27.4%)	.85
Complete margins	4 (1.3%)	1 (0.3%)	.62
Narrow margins	18 (5.9%)	7 (2.3%)	.82
Not recorded margins	3 (1%)	0	NA
Median time from surgery to radiation therapy (d)	32 (range, 4‐277)	36 (range, 9‐173)	.09